| 摘要 |
FIELD: medicine, neurology. SUBSTANCE: during the stage of exacerbation patients with multiple sclerosis should be intravenously injected by drops with human interleukin-2 (h-IL-2) preparation, for example, roncoleukin, at the dosage of not less than 1 mln IU once per 7d. The method enables to considerably shorten therapy terms in patients with multiple sclerosis at the background of pronounced immune deficiency, decrease the number of relapses and prolong labor capacity period in patients with multiple sclerosis. EFFECT: higher efficiency of therapy. 1 cl, 2 ex, 2 tbl
|
